Skip to main content
CB

CURO BIOSCIENCES PRIVATE LIMITED

The startup develops a non-invasive cancer detection kit that analyzes saliva samples to provide at-home diagnostic reports and consultations. This technology enables early-stage cancer detection, making it accessible and affordable for users to monitor their health.

Nagpur, India9300+ followers
Updated 2 months ago

Funding

$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

AK
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Oral cancer is a significant global health concern, often detected late due to reliance on visual exams and symptomatic presentation, leading to high mortality rates. Traditional detection methods often miss early-stage cancers, reducing the chances of successful treatment and increasing the risk of metastasis.

Solution

Erly Sign offers a non-invasive, at-home saliva test for the early detection of oral precancerous conditions. The test analyzes saliva samples for specific biomarkers, providing a risk assessment (low, moderate, or high) that indicates the likelihood of developing oral cancer. Users collect their saliva sample in the provided kit, register the kit online, and ship it back to the lab using a prepaid label. Test results are delivered digitally, with options for consultations with nutritionists, dentists, or oncologists to guide further action based on the risk level.

Target Audience

The primary target audience includes men over 40 and women over 50, particularly those with risk factors such as tobacco use, heavy alcohol consumption, HPV infection, or a weakened immune system.

Features

  • Non-invasive saliva collection requiring no needles or blood draws
  • At-home testing, eliminating the need for clinic visits and wait times
  • Analysis of saliva biomarkers to assess the risk of precancerous conditions
  • Risk assessment reported as low, moderate, or high
  • Digital delivery of test results via email and online account
  • Option for consultations with healthcare professionals based on risk level
  • Preservative solution that stabilizes saliva samples for up to a year
  • Prepaid shipping label for convenient sample return
This profile is AI-generated and may contain inaccuracies.